163 related articles for article (PubMed ID: 8675220)
21. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.
Barackman JD; Ott G; O'Hagan DT
Infect Immun; 1999 Aug; 67(8):4276-9. PubMed ID: 10417205
[TBL] [Abstract][Full Text] [Related]
22. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.
Takahashi I; Kiyono H; Jackson RJ; Fujihashi K; Staats HF; Hamada S; Clements JD; Bost KL; McGhee JR
Infect Immun; 1996 Apr; 64(4):1290-8. PubMed ID: 8606092
[TBL] [Abstract][Full Text] [Related]
23. A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT).
Chikwamba R; Cunnick J; Hathaway D; McMurray J; Mason H; Wang K
Transgenic Res; 2002 Oct; 11(5):479-93. PubMed ID: 12437079
[TBL] [Abstract][Full Text] [Related]
24. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.
Brereton CF; Sutton CE; Ross PJ; Iwakura Y; Pizza M; Rappuoli R; Lavelle EC; Mills KH
J Immunol; 2011 May; 186(10):5896-906. PubMed ID: 21490151
[TBL] [Abstract][Full Text] [Related]
25. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein.
Wu CM; Chung TC
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):354-65. PubMed ID: 17651125
[TBL] [Abstract][Full Text] [Related]
26. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B.
Lauterslager TG; Florack DE; van der Wal TJ; Molthoff JW; Langeveld JP; Bosch D; Boersma WJ; Hilgers LA
Vaccine; 2001 Mar; 19(17-19):2749-55. PubMed ID: 11257419
[TBL] [Abstract][Full Text] [Related]
27. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
[TBL] [Abstract][Full Text] [Related]
28. Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin.
Hayward CM; O'Gaora P; Young DB; Griffin GE; Thole J; Hirst TR; Castello-Branco LR; Lewis DJ
Vaccine; 1999 Mar; 17(9-10):1272-81. PubMed ID: 10195640
[TBL] [Abstract][Full Text] [Related]
29. Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit.
Beyer AJ; Wang K; Umble AN; Wolt JD; Cunnick JE
Environ Health Perspect; 2007 Mar; 115(3):354-60. PubMed ID: 17431483
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.
Clements JD; Hartzog NM; Lyon FL
Vaccine; 1988 Jun; 6(3):269-77. PubMed ID: 3048010
[TBL] [Abstract][Full Text] [Related]
31. Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector.
Cárdenas L; Clements JD
Infect Immun; 1993 Nov; 61(11):4629-36. PubMed ID: 8406860
[TBL] [Abstract][Full Text] [Related]
32. Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB).
Nashar TO; Hirst TR
Vaccine; 1995 Jun; 13(9):803-10. PubMed ID: 7483801
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens.
Miller T; Fanton M; Nickelson S; Mason H; Webb S
Avian Pathol; 2012 Oct; 41(5):441-9. PubMed ID: 22928883
[TBL] [Abstract][Full Text] [Related]
34. Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.
Melkebeek V; Verdonck F; Goddeeris BM; Cox E
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):199-214. PubMed ID: 17331591
[TBL] [Abstract][Full Text] [Related]
35. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.
Chong C; Friberg M; Clements JD
Vaccine; 1998 Apr; 16(7):732-40. PubMed ID: 9562694
[TBL] [Abstract][Full Text] [Related]
36. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.
Douce G; Giannelli V; Pizza M; Lewis D; Everest P; Rappuoli R; Dougan G
Infect Immun; 1999 Sep; 67(9):4400-6. PubMed ID: 10456880
[TBL] [Abstract][Full Text] [Related]
37. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.
Hazama M; Mayumi-Aono A; Miyazaki T; Hinuma S; Fujisawa Y
Immunology; 1993 Apr; 78(4):643-9. PubMed ID: 8388365
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
Norton EB; Branco LM; Clements JD
PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
[TBL] [Abstract][Full Text] [Related]
39. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
40. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
